Companies and academic labs around the world are racing to build next-generation devices and artificial intelligence that can monitor and decode brain activity. With as many as 500,000 people a year world-wide suffering spinal-cord injuries and strokes becoming more common among younger patients because of Covid-19, the need is huge, neuroscientists said.
Success hinges on better understanding normal brain function and being able to build durable, accurate and safe devices that work outside research settings. Companies including Silicon Valley startup Synchron Inc., which developed the sensor in Mr. O’Keefe’s brain, are working on technology to access the brain while limiting the potential for damage.
Experts said Synchron’s Stentrode has the potential to expand mobility options for patients who can’t move. So far, its accuracy varies. Experts said that could improve with training or software updates.
Read more at WSJ.